Randomized, Controlled Study of CF Patients Between 3 Months and Less Than 7 Years

NCT01082367 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Treatment of Early Pulmonary Infections With P. Aeruginosa in Cystic Fibrosis Patients

Interventions

DRUG: TOBI
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals